Overview
Stephen Siegel is an Urologist in Boulder, Colorado. Dr. Siegel is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Enlarged Prostate (BPH), Obstructive Uropathy, Familial Prostate Cancer, Prostate Cancer, and Ureteroscopy. Dr. Siegel is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2750 Broadway St, Boulder, CO 80304
Poudre Valley Medical Group LLC
Michael Eddy is an Urologist in Fort Collins, Colorado. Dr. Eddy is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Reconstructive Urology Surgery, and Nephrectomy. Dr. Eddy is currently accepting new patients.
Advanced Urology PLLC
Michael Ferrandino is an Urologist in Westminster, Colorado. Dr. Ferrandino is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Ureterocele, Lithotripsy, and Ureteroscopy. Dr. Ferrandino is currently accepting new patients.
University Physicians Incorporated
Janet Kukreja is an Urologist and a General Surgeon in Aurora, Colorado. Dr. Kukreja is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Reconstructive Urology Surgery. Dr. Kukreja is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Enlarged Prostate (BPH)Dr. Siegel isDistinguished. Learn about Enlarged Prostate (BPH).
- Obstructive UropathyDr. Siegel isDistinguished. Learn about Obstructive Uropathy.
- Advanced
- BalanitisDr. Siegel isAdvanced. Learn about Balanitis.
- Bilateral HydronephrosisDr. Siegel isAdvanced. Learn about Bilateral Hydronephrosis.
- Bladder CancerDr. Siegel isAdvanced. Learn about Bladder Cancer.
- Bladder StonesDr. Siegel isAdvanced. Learn about Bladder Stones.
- BoilsDr. Siegel isAdvanced. Learn about Boils.
- CarbuncleDr. Siegel isAdvanced. Learn about Carbuncle.
- Experienced
- Acute CystitisDr. Siegel isExperienced. Learn about Acute Cystitis.
- Bacterial ProstatitisDr. Siegel isExperienced. Learn about Bacterial Prostatitis.
- Bladder Outlet ObstructionDr. Siegel isExperienced. Learn about Bladder Outlet Obstruction.
- ChoriocarcinomaDr. Siegel isExperienced. Learn about Choriocarcinoma.
- Chromophobe Renal Cell CarcinomaDr. Siegel isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Siegel isExperienced. Learn about Clear Cell Sarcoma.